Inside U.S. Regulations

Covering Adult-Use Cannabis, Drug Trafficking, Adverse Event Monitoring System, GENIUS Act, International Trafficking. Explore updates on adult-use cannabis licensing, drug and firearms trafficking convictions, new FDA adverse event monitoring system, and key discussions on stablecoin regulation under the GENIUS Act. Coverage includes international trafficking and regulatory enforcement.

Show Notes

This episode covers vital regulatory updates across multiple sectors including adult-use cannabis, drug trafficking enforcement, advanced adverse event monitoring systems, the GENIUS Act's impact on stablecoin regulation, and international trafficking challenges.

Among the highlights, the New York Cannabis Control Board has delegated authority to approve adult-use cannabis licenses, with strict compliance and municipal input requirements to ensure effective local governance.

In law enforcement, significant convictions were reported involving firearm trafficking across U.S.-Canada borders and drug trafficking offenses, underscoring enhanced cross-border cooperation and stringent sentencing.

The FDA’s transition to the new Adverse Event Monitoring System (AEMS) introduces AI-driven analytics and a centralized reporting platform, enhancing pharmacovigilance and public health protection.

For more information, visit the Carver Agents website.

Articles mentioned:
  1. Watch Live
  2. IAIS concludes multi-year cycle of Holistic Framework implementation assessments
  3. Former International Trucker Sentenced to Federal Prison for Conspiring to Traffic Guns Purchased in Florida and Found at Canadian Crime Scenes (DOJ)
  4. Risk Minimization Action Plans (RiskMAPs) for Approved Products
  5. London Man Sentenced for Methamphetamine Trafficking (DOJ)
  6. No. 2026-20 - 2026-04-02 - Resolution to Issue Certain Adult-Use Cannabis Licenses
  7. New Orleans Man Guilty of 2 Counts of Firearm Possession in Furtherance of Drug Trafficking (DOJ)
  8. New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)
  9. Attorney General Bonta Opposes Trump Administration Proposal Targeting Diversity, Equity, and Inclusion Programs
  10. Attorney General Bonta Opposes Trump Administration Proposal Targeting Diversity, Equity, and Inclusion Programs

What is Inside U.S. Regulations?

Regulatory news, updates, and insights for USA presented by the Carver Agents team

Welcome to Carver's USA Regulatory Updates for April 05, 2026.

The United States continues to focus on stablecoin regulation with a panel discussion held on March 31, 2026. The event addressed key regulatory questions and implementation challenges related to stablecoins, emphasizing their growing role in the payment system and potential systemic risks. The discussion included examination of how regulation will be carried out, assessment of systemic risk management, and clarification of banks' roles in stablecoins.

The International Association of Insurance Supervisors, or IAIS, has completed its 2025 Targeted Jurisdictional Assessment, which included the United States among other countries. This assessment evaluated the implementation of supervisory standards related to Internationally Active Insurance Groups determination, macroprudential supervision, liquidity risk management, and crisis management frameworks. The IAIS reaffirmed the importance of maintaining robust IAIG determination and macroprudential supervision processes, as well as implementing enforceable liquidity risk management and crisis management frameworks to strengthen global financial stability in the insurance sector.

In enforcement news, the United States Department of Justice reported the conviction and sentencing of Erhan John Er for conspiring to traffic firearms purchased in Florida and found at Canadian crime scenes. This case highlights the importance of coordinated law enforcement efforts between the United States and Canada to disrupt illegal firearms trafficking networks.

Also from the Department of Justice, Tyrone Whittington of New Orleans pleaded guilty to two counts of firearm possession in furtherance of drug trafficking. He faces mandatory minimum sentences of five years per count, which must be served consecutively to other sentences, potential life imprisonment, fines up to $250,000, supervised release of up to five years, and a mandatory special assessment fee.

Additionally, a London man was sentenced in the United States to 220 months in federal prison for possession with intent to distribute methamphetamine. He is required to serve 85 percent of his sentence followed by 10 years of supervised release.

Turning to regulatory developments in the pharmaceutical sector, the U.S. Food and Drug Administration has introduced voluntary Risk Minimization Action Plans, or RiskMAPs, for approved animal veterinary products. These plans include tools such as provider training, certification programs, informed owner consent, and enhanced pharmacovigilance to minimize risks while preserving drug benefits. Sponsors implementing RiskMAPs must include evaluation plans to periodically assess their effectiveness.

The FDA also transitioned its adverse event monitoring system from the FDA Adverse Event Reporting System, or FAERS, to the new Adverse Event Monitoring System, AEMS, effective March 11, 2026. AEMS incorporates advanced analytics, artificial intelligence-based tools, and a centralized platform for adverse event reporting, consumer complaints, regulatory misconduct, and whistleblower submissions. This upgrade aims to improve regulatory risk monitoring and public health protection through more consistent and timely identification of potential safety signals.

In cannabis regulation, the New York Cannabis Control Board delegated authority to the Office of Cannabis Management to issue responses to municipalities and approve adult-use cannabis licenses as of April 2, 2026. Licensees must not begin operations until all additional requirements and written approvals from the Office’s compliance team are completed. Municipalities and community boards have 30 days, with a possible 30-day extension, to submit opinions regarding license issuance. Licensees must comply with local restrictions and regulatory requirements.

Finally, a coalition of state attorneys general led by California Attorney General Rob Bonta has opposed a proposal by the U.S. General Services Administration. The proposal would require federal funding applicants and recipients to certify compliance with certain executive orders and Department of Justice guidance restricting diversity, equity, and inclusion programs. The coalition argues that these amendments impose duplicative, unnecessary burdens, violate federal law, and threaten lawful DEI activities by imposing unclear and coercive certification requirements.

That wraps up today's regulatory updates. Visit carveragents.ai for more information.